140 related articles for article (PubMed ID: 34716713)
1. Morphological landscapes from high content imaging reveal cytokine priming strategies that enhance mesenchymal stromal cell immunosuppression.
Andrews SH; Klinker MW; Bauer SR; Marklein RA
Biotechnol Bioeng; 2022 Feb; 119(2):361-375. PubMed ID: 34716713
[TBL] [Abstract][Full Text] [Related]
2. Differential response of mesenchymal stromal cells (MSCs) to type 1 ex vivo cytokine priming: implications for MSC therapy.
Burnham AJ; Foppiani EM; Goss KL; Jang-Milligan F; Kamalakar A; Bradley H; Goudy SL; Trochez CM; Dominici M; Daley-Bauer L; Gibson G; Horwitz EM
Cytotherapy; 2023 Dec; 25(12):1277-1284. PubMed ID: 37815775
[TBL] [Abstract][Full Text] [Related]
3. Morphological profiling using machine learning reveals emergent subpopulations of interferon-γ-stimulated mesenchymal stromal cells that predict immunosuppression.
Marklein RA; Klinker MW; Drake KA; Polikowsky HG; Lessey-Morillon EC; Bauer SR
Cytotherapy; 2019 Jan; 21(1):17-31. PubMed ID: 30503100
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors.
Saldaña L; Bensiamar F; Vallés G; Mancebo FJ; García-Rey E; Vilaboa N
Stem Cell Res Ther; 2019 Feb; 10(1):58. PubMed ID: 30760316
[TBL] [Abstract][Full Text] [Related]
5. Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity.
Klinker MW; Marklein RA; Lo Surdo JL; Wei CH; Bauer SR
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2598-E2607. PubMed ID: 28283659
[TBL] [Abstract][Full Text] [Related]
6. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
[TBL] [Abstract][Full Text] [Related]
9. High throughput screening of mesenchymal stromal cell morphological response to inflammatory signals for bioreactor-based manufacturing of extracellular vesicles that modulate microglia.
Larey AM; Spoerer TM; Daga KR; Morfin MG; Hynds HM; Carpenter J; Hines KM; Marklein RA
bioRxiv; 2023 Nov; ():. PubMed ID: 38014258
[TBL] [Abstract][Full Text] [Related]
10. High throughput screening of mesenchymal stromal cell morphological response to inflammatory signals for bioreactor-based manufacturing of extracellular vesicles that modulate microglia.
Larey AM; Spoerer TM; Daga KR; Morfin MG; Hynds HM; Carpenter J; Hines KM; Marklein RA
Bioact Mater; 2024 Jul; 37():153-171. PubMed ID: 38549769
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics and cytokine profiling of mesenchymal stromal cells identify markers predictive of T-cell suppression.
Maughon TS; Shen X; Huang D; Michael AOA; Shockey WA; Andrews SH; McRae JM; Platt MO; Fernández FM; Edison AS; Stice SL; Marklein RA
Cytotherapy; 2022 Feb; 24(2):137-148. PubMed ID: 34696960
[TBL] [Abstract][Full Text] [Related]
12. Effect of pro-inflammatory cytokine priming and storage temperature of the mesenchymal stromal cell (MSC) secretome on equine articular chondrocytes.
Jammes M; Contentin R; Audigié F; Cassé F; Galéra P
Front Bioeng Biotechnol; 2023; 11():1204737. PubMed ID: 37720315
[No Abstract] [Full Text] [Related]
13. Unveiling the functional heterogeneity of cytokine-primed human umbilical cord mesenchymal stem cells through single-cell RNA sequencing.
Hu Z; Li D; Wu S; Pei K; Fu Z; Yang Y; Huang Y; Yang J; Liu C; Hu J; Cai C; Liao Y
Cell Biosci; 2024 Mar; 14(1):40. PubMed ID: 38532459
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming.
Romieu-Mourez R; François M; Abate A; Boivin MN; Birman E; Bailey D; Bramson JL; Forner K; Young YK; Medin JA; Galipeau J
Cancer Res; 2010 Oct; 70(20):7742-7. PubMed ID: 20924101
[TBL] [Abstract][Full Text] [Related]
15. Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.
Cui R; Rekasi H; Hepner-Schefczyk M; Fessmann K; Petri RM; Bruderek K; Brandau S; Jäger M; Flohé SB
Stem Cell Res Ther; 2016 Jul; 7(1):88. PubMed ID: 27388156
[TBL] [Abstract][Full Text] [Related]
16. A novel direct co-culture assay analyzed by multicolor flow cytometry reveals context- and cell type-specific immunomodulatory effects of equine mesenchymal stromal cells.
Hillmann A; Paebst F; Brehm W; Piehler D; Schubert S; Tárnok A; Burk J
PLoS One; 2019; 14(6):e0218949. PubMed ID: 31247035
[TBL] [Abstract][Full Text] [Related]
17. Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation.
Selich A; Zimmermann K; Tenspolde M; Dittrich-Breiholz O; von Kaisenberg C; Schambach A; Rothe M
Stem Cell Res Ther; 2019 Sep; 10(1):285. PubMed ID: 31547865
[TBL] [Abstract][Full Text] [Related]
18. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
[TBL] [Abstract][Full Text] [Related]
19. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
20. Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion.
Srinivasan A; Sathiyanathan P; Yin L; Liu TM; Lam A; Ravikumar M; Smith RAA; Loh HP; Zhang Y; Ling L; Ng SK; Yang YS; Lezhava A; Hui J; Oh S; Cool SM
Cytotherapy; 2022 May; 24(5):456-472. PubMed ID: 35227601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
